Manns, Michael P. http://orcid.org/0000-0002-4485-8856
Maasoumy, Benjamin
Article History
Accepted: 16 March 2022
First Online: 20 May 2022
Competing interests
: M.P.M. received speaker and/or consulting fees and/or grant or research support from AbbVie, BMS, Gilead, Merck/MSD and Janssen. B.M. received speaker and/or consulting fees from Abbott Molecular, Astellas, Intercept, Falk, AbbVie, Bristol-Myers Squibb, Fujirebio, Janssen-Cilag, Merck/MSD and Roche. He also received research support from Abbott Molecular and Roche.
Free to read: This content has been made available to all.